Solventum Corporation
SOLV
$81.01
-$1.41-1.71%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.26B | 8.33B | 8.40B | 8.39B | 8.31B |
| Total Other Revenue | 1.00M | -- | -- | -- | -- |
| Total Revenue | 8.26B | 8.33B | 8.40B | 8.39B | 8.31B |
| Cost of Revenue | 3.83B | 3.87B | 3.83B | 3.79B | 3.74B |
| Gross Profit | 4.43B | 4.46B | 4.57B | 4.60B | 4.56B |
| SG&A Expenses | 3.08B | 3.06B | 3.08B | 3.00B | 2.93B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.63B | 7.65B | 7.67B | 7.55B | 7.44B |
| Operating Income | 628.00M | 676.00M | 736.00M | 843.00M | 872.00M |
| Income Before Tax | 1.69B | 1.71B | 1.67B | 322.00M | 315.00M |
| Income Tax Expenses | 259.00M | 157.00M | 145.00M | -58.00M | -64.00M |
| Earnings from Continuing Operations | 1.43K | 1.56K | 1.52K | 380.00 | 379.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.43B | 1.56B | 1.52B | 380.00M | 379.00M |
| EBIT | 628.00M | 676.00M | 736.00M | 843.00M | 872.00M |
| EBITDA | 1.12B | 1.17B | 1.26B | 1.38B | 1.42B |
| EPS Basic | 8.22 | 8.93 | 8.75 | 2.19 | 2.19 |
| Normalized Basic EPS | 1.19 | 1.19 | 1.16 | 1.48 | 1.42 |
| EPS Diluted | 8.16 | 8.87 | 8.69 | 2.17 | 2.17 |
| Normalized Diluted EPS | 1.19 | 1.18 | 1.15 | 1.47 | 1.42 |
| Average Basic Shares Outstanding | 697.00M | 696.50M | 695.50M | 694.60M | 693.70M |
| Average Diluted Shares Outstanding | 701.80M | 701.10M | 699.90M | 698.40M | 696.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |